<DOC>
	<DOCNO>NCT01509079</DOCNO>
	<brief_summary>The Purpose study determine whether vitamin D3 supplement decrease muscle bone pain report woman take Aromatase Inhibitors .</brief_summary>
	<brief_title>Vitamin D3 Effects Musculoskeletal Symptoms With Use Aromatase Inhibitors</brief_title>
	<detailed_description>This project determine efficacy vitamin D3 supplement reduce side effect treatment aromatase inhibitor woman history breast cancer evidence current disease . The aromatase inhibitor ( AI ) become critical component adjuvant therapy population , cause bone pain , joint pain , joint stiffness , muscle weakness approximately 40 % patient . These symptom , refer aromatase inhibitor-associated musculoskeletal symptom ( AIMSS ) , decrease quality life medication adherence . Identifying effective way decrease symptom may allow long adherent medication use thus may improve disease-free survival . We hypothesize vitamin D3 may decrease symptom associate use aromatase inhibitor .</detailed_description>
	<mesh_term>Arthralgia</mesh_term>
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Age â‰¥ 18 year Women history stage IIIIa invasive breast cancer History hormonereceptor positive cancer ( either ER + PR + ) Are prescribe take anastrozole , letrozole exemestane least one month least 7 month AI treatment remain Are experience AIMSS Unable read understand English History psychiatric disability affect informed consent compliance drug intake Malabsorption syndrome inability take oral medication Has less 7 month AI therapy remain</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>